Loading insider details...
Beta
Latest Form 4 (Jun 23, 2026): Exercise/Conversion of 18,880 NVAX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | NOVAVAX INC (NVAX) | Exercise/Conversion | 18,880 | n/a |
| Apr 27, 2026 | AMICUS THERAPEUTICS, INC. (FOLD) | Disposition to Issuer | 94,631 | $1.37M |
| Jun 24, 2025 | NOVAVAX INC (NVAX) | Grant/Award | 28,326 | $181.9K |
| Jun 16, 2025 | NOVAVAX INC (NVAX) | Exercise/Conversion | 10,420 | n/a |
| Jun 6, 2025 | AMICUS THERAPEUTICS, INC. (FOLD) | Grant/Award | 20,414 | n/a |
| Feb 6, 2025 | NOVAVAX INC (NVAX) | Grant/Award | 2,029 | $9.9K |
| Jun 14, 2024 | NOVAVAX INC (NVAX) | Exercise/Conversion | 6,670 | n/a |
| Jun 7, 2024 | AMICUS THERAPEUTICS, INC. (FOLD) | Grant/Award | 11,847 | n/a |
| Mar 6, 2024 | AMICUS THERAPEUTICS, INC. (FOLD) | Exercise/Conversion | 7,500 | $21.0K |
| Jun 13, 2023 | NOVAVAX INC (NVAX) | Exercise/Conversion | 3,100 | n/a |